Dear Friends,

The Corey/Miller Family strongly supports critical Melanoma cancer research at Memorial Sloan Kettering—where new discoveries are revolutionizing how cancer is diagnosed and treated.  Join us in making a difference by donating today!

On October 3rd, 2020, Andrea Corey was diagnosed with Stage IV Melanoma.  Six weeks later, on November 15, 2020, Andrea passed.  While currently Melanoma has a poor 5-year survival rate of 15-20%, MSK is at the forefront of immunotherapy, including clinical trials and research.  While Andrea was only able to receive one treatment, increased research funds will allow Melanoma patients to receive cutting edge treatments, and will allow earlier diganosis, leading to more successful outcomes.  

Donors Fuel Progress

When you give to MSK, you're making a direct impact: from innovative research that can move newly discovered drugs into clinical trials, to the cancer treatment and care patients receive every day.

Fundraising efforts can lead to important and life-changing breakthroughs in cancer research—making it possible for scientists to overcome the hurdles of funding gaps. Philanthropy provides the tools they need to swiftly pursue promising research initiatives.

MSK Leads Cancer Care

Your gift supports the best and brightest researchers in their work to outsmart cancer. These innovative thinkers are focused on fighting every form of the disease. The close collaboration between MSK's doctors and researchers is unique and one of its greatest strengths—ensuring that drugs and therapies developed in the lab can be moved quickly to the clinic.

Together, we can join the leaders in cancer research by funding a future with better outcomes for people with cancer and their families—not just at MSK, but around the world.

Every dollar brings more hope. Thank you!